Valuation: CellaVision AB

Market Cap 3.23B 335M 293M 271M 249M 471M 32.27B 479M 1.27B 15.77B 1.26B 1.23B 54.37B P/E 2026 *
23.7x
P/E 2027 * 18.9x
Enterprise Value 3.01B 313M 274M 252M 232M 440M 30.12B 447M 1.18B 14.72B 1.18B 1.15B 50.75B EV / Sales 2026 *
3.97x
EV / Sales 2027 * 3.5x
Free-Float
83.08%
Yield 2026 *
2.03%
Yield 2027 * 2.36%
1 day+1.34%
1 week-0.88%
Current month-0.59%
1 month-2.03%
3 months-10.09%
6 months-12.53%
Current year-13.87%
1 week 131.8
Extreme 131.8
139.8
1 month 131.8
Extreme 131.8
149.6
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 70.5
Extreme 70.5
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-12Buy 760 0.0032%
06-09Buy

Founder

33,000 0.1384%
06-09Buy

Director

314 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-0.88%-24.44%-26.73% 333M
-1.04%+6.55%+17.75%-20.60% 17.72B
+6.00%+4.78%+19.69%+102.41% 1.64B
+3.23%+5.68%-34.78%-78.07% 1.2B
-0.83%-6.78%-35.44%+11.51% 1.03B
+3.25%+7.14%-25.93%-51.63% 638M
+0.78%+1.80%-38.30%-55.23% 558M
+2.08%+0.28%+39.59%-52.82% 445M
+2.10%+0.80%-54.30%-59.11% 378M
-1.35%+2.16%+23.85%+4.95% 309M
Average +1.57%+2.32%-11.23%-22.53% 2.43B
Weighted average by Cap. -0.01%+6.30%+9.35%-16.35%

Financials

2026 *2027 *
Net sales 760M 78.95M 69.03M 63.68M 58.54M 111M 7.6B 113M 298M 3.71B 297M 290M 12.8B 851M 88.34M 77.23M 71.24M 65.49M 124M 8.5B 126M 334M 4.15B 332M 324M 14.32B
Net income 136M 14.16M 12.38M 11.42M 10.5M 19.9M 1.36B 20.24M 53.51M 666M 53.19M 52.02M 2.3B 175M 18.17M 15.89M 14.66M 13.47M 25.53M 1.75B 25.97M 68.66M 855M 68.25M 66.76M 2.95B
Net Debt -215M -22.34M -19.54M -18.02M -16.57M -31.39M -2.15B -31.93M -84.42M -1.05B -83.91M -82.07M -3.62B -254M -26.36M -23.05M -21.26M -19.55M -37.04M -2.54B -37.67M -99.6M -1.24B -99.01M -96.84M -4.27B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
15/07/26 SEK 135.40 +0.74% 25,981
14/07/26 SEK 134.40 -2.89% 32,098
13/07/26 SEK 138.40 0.00% 21,004
10/07/26 SEK 138.40 +2.67% 12,538
09/07/26 SEK 134.80 +2.12% 16,039
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
135.40SEK
Average target price
171.25SEK
Spread / Average Target
+26.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock